内镜鼻窦手术的术者特异性表现评估
该回顾性研究基于加拿大阿尔伯塔省行政数据库,纳入2007至2010年接受初次内镜鼻窦手术的2168例成人慢性鼻窦炎患者,以风险调整的5年修正手术率评估术者表现。结果示粗5年修正率为10.6%(范围2.4%-28.6%),7名术者(16%)表现低于预期,2名(5%)高于预期;鼻息肉、年全身激素疗程数及同期鼻中隔成形术与修正率显著相关。
要点
- 风险调整后,16%术者5年修正率低于预期,5%高于预期。
- 鼻息肉(OR 2.07)和更多年全身激素疗程(OR 1.33)与修正率升高相关。
- 同期鼻中隔成形术与修正率降低相关(OR 0.70)。
核心结论
- 评估术者特异性表现可为质量改进提供信息;多数术者风险调整后5年修正率相当,但16%术者表现低于预期,提示有改进医疗质量的潜力。
研究设计与样本
- 回顾性研究,使用基于人群的行政数据库,纳入2007年3月1日至2010年3月1日在加拿大阿尔伯塔省接受初次内镜鼻窦手术的成人(≥18岁)慢性鼻窦炎患者,随访至2015年以提供5年随访。
主要发现
- 共43名术者为2168例患者行初次内镜鼻窦手术;5年内239例患者接受修正手术,平均粗5年修正率为10.6%(范围2.4%-28.6%)。
- 应用风险调整模型及95%CI后,7名术者(16%)表现低于预期,2名(5%)高于预期。
- 鼻息肉与术者特异性5年修正率显著相关(OR 2.07;95%CI 1.59-2.70)。
- 更多年全身皮质激素疗程与修正率显著相关(OR 1.33;95%CI 1.19-1.48)。
- 同期鼻中隔成形术与修正率显著相关(OR 0.70;95%CI 0.55-0.89)。
关键数值与推荐
- 主要结局为5年观察到的和风险调整后的内镜鼻窦手术修正率。
- 使用逻辑回归建立主要结局的风险调整模型。
临床怎么用
- 术者特异性风险调整的5年修正率可作为质量指标,为质量改进提供信息。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Several identified factors have raised questions concerning the quality of care for endoscopic sinus surgery (ESS), including the presence of large geographic variation in the rates and extent of surgery, poorly defined indications, and lack of ESS-specific quality metrics. Combined with the risk of major complications, ESS represents a high-value target for quality improvement. OBJECTIVE: To evaluate differences in surgeon-specific performance for ESS using a risk-adjusted, 5-year ESS revision rate as a quality metric. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study used a population-based administrative database to study adults (≥18 years of age) with chronic rhinosinusitis (CRS) who underwent primary ESS in Alberta, Canada, between March 1, 2007, and March 1, 2010. The study period ended in 2015 to provide 5 years of follow-up. INTERVENTIONS: Endoscopic sinus surgery for CRS. MAIN OUTCOMES AND MEASURES: Primary outcomes were the 5-year observed and risk-adjusted ESS revision rate. Logistic regression was used to develop a risk adjustment model for the primary outcome. RESULTS: A total of 43 individual surgeons performed primary ESS in 2168 patients with CRS. Within 5 years after the primary ESS procedure, 239 patients underwent revision ESS, and the mean crude 5-year ESS revision rate was 10.6% (range, 2.4%-28.6%). After applying the risk adjustment model and 95% CI to each surgeon, 7 surgeons (16%) had lower-than-expected performance and 2 surgeons (5%) had higher-than-expected performance. Three variables had significant associations with surgeon-specific, 5-year ESS revision rates: presence of nasal polyps (odds ratio [OR], 2.07; 95% CI, 1.59-2.70), more annual systemic corticosteroid courses (OR, 1.33; 95% CI, 1.19-1.48), and concurrent septoplasty (OR, 0.70; 95% CI, 0.55-0.89). CONCLUSIONS AND RELEVANCE: Evaluating surgeon-specific performance for ESS may provide information to assist in quality improvement. Although most surgeons had comparable risk-adjusted, 5-year ESS revision rates, 16% of surgeons had lower-than-expected performance, indicating a potential to improve quality of care. Future studies are needed to evaluate more surgeon-specific variables and validate a risk adjustment model to provide appropriate feedback for quality improvement.
引用
- Rudmik L, Xu Y, Alt JA, et al. Evaluating Surgeon-Specific Performance for Endoscopic Sinus Surgery. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28655057. doi:10.1001/jamaoto.2017.0752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。